A ligand discovery toolbox for the WWE domain family of human E3 ligases by Münzker, L, Kimani, SW, Fowkes, MM, Dong, A, Zheng, H, Li, Y, Dasovich, M, Zak, KM, Leung, AKL, Elkins, JM, Kessler, D, Arrowsmith, CH, Halabelian, L, Böttcher, J

Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways by Feng, S, Marhon, SA, Sokolowski, DJ, D’Costa, A, Soares, F, Mehdipour, P, Ishak, C, Loo Yau, H, Ettayebi, I, Patel, PS, Chen, R, Liu, J, Zuzarte, PC, Ho, KC, Ho, B, Ning, S, Huang, A, Arrowsmith, CH, Wilson, MD, Simpson, JT, De Carvalho, DD

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer by Wu, Q, Nie, DY, Ba-Alawi, W, Ji, Y, Zhang, Z, Cruickshank, J, Haight, J, Ciamponi, FE, Chen, J, Duan, S, Shen, Y, Liu, J, Marhon, SA, Mehdipour, P, Szewczyk, MM, Dogan-Artun, N, Chen, W, Zhang, LX, Deblois, G, Prinos, P, Massirer, KB, Barsyte-Lovejoy, D, Jin, J, De Carvalho, DD, Haibe-Kains, B, Wang, X, Cescon, DW, Lupien, M, Arrowsmith, CH

Target 2035 - an update on private sector contributions by Ackloo, S, Antolin, AA, Bartolome, JM, Beck, H, Bullock, A, Betz, UAK, Böttcher, J, Brown, PJ, Chaturvedi, M, Crisp, A, Daniels, D, Dreher, J, Edfeldt, K, Edwards, AM, Egner, U, Elkins, J, Fischer, C, Glendorf, T, Goldberg, S, Hartung, IV, Hillisch, A, Homan, E, Knapp, S, Köster, M, Krämer, O, Llaveria, J, Lessel, U, Lindemann, S, Linderoth, L, Matsui, H, Michel, M, Montel, F, Mueller-Fahrnow, A, Müller, S, Owen, DR, Saikatendu, KS, Santhakumar, V, Sanderson, W, Scholten, C, Schapira, M, Sharma, S, Shireman, B, Sundström, M, Todd, MH, Tredup, C, Venable, J, Willson, TM, Arrowsmith, CH